Russian defense minister: India’s SCO accession opens up new prospects for cooperationMilitary & Defense June 23, 13:19
Russia and India to hold first combined forces drills in fallMilitary & Defense June 23, 13:14
Serbian president confident EU accession will not aggravate relations with RussiaWorld June 23, 13:14
Press review: Reinforcements from Asia possible in Syria and Russia mulls data leak woesPress Review June 23, 13:00
2017 FIFA Confederations Cup in Russia is 'so far, so good' — Germany’s Emre CanSport June 23, 11:24
NHL says Olympic participation matter closedSport June 23, 11:12
Russia’s telecom watchdog may block Telegram messenger in RussiaBusiness & Economy June 23, 9:15
Russian warships fire Kalibr cruise missiles, destroy IS arms depots in SyriaMilitary & Defense June 23, 9:07
Kazakh foreign minister denies talks on sending troops to SyriaWorld June 23, 8:05
MOSCOW, May 16, 22:47 /ITAR-TASS/. Russian government is to saturate the domestic market with 90% of medications produced inside the country before 2018, prime minister Dmitry Medvedev wrote on his social network account on Friday assessing a session of the presidential Commission for Modernisation and Technological Development of Russia's Economy that was held in St. Petersburg on Friday and was focused on Russia’s pharmaceutical market.
“Russia must manufacture vital drugs itself,” Medvedev said. “Our target is to start producing 90% of these essential medications inside the country till 2018,” the prime minister said.
Speaking at the session, Medvedev said that, in financial terms, medicinal products in Russia would surpass 1,000 billion roubles (about 28.8 million U.S. dollars) on the domestic market in near future but domestically produced drugs occupied a rather small niche there.
In 2013, the volume of the Russian pharmaceutical market climbed eight percent to amount to nearly 820 billion roubles (over 23 billion U.S. dollars). “Forecasts say in several years’ time the market will exceed a trillion roubles (about 28.8 billion U.S. dollars),” he said.
Pharmaceuticals totalled about 200 billion roubles (5.76 billion U.S. dollars) on the market and the segment “has good prospects for a speedy growth.”
“Unfortunately, the demand for these products is still satisfied by the foreign manufacturers, while a share of the domestic products on the Russian market is about one fifth and medications occupy slightly over one fourth [of the supplies],” he said.